2Valesin G,Priori R,Francir A,et al.Central Nervous system involvement in systemic lupus erthematoses:a new therapeutic approach with intrathecal dexamethasone and methotrexate[J].Ann Rew Immunopthoi,1994,313-321.
1[1]Yee CS, Hussein H, Skan J, et al. Association of damadge with autoantibody profile, age, race sex and disease duration in SLE[J]. Rheumatol, 2003,42: 276-279.
2[2]Backer SB, Rovira JR, Campion EW, et al. Late onset systemic lupus erythematosus[ J]. Am J Med, 1979,66: 727-732.
3[3]Pu JS, Lou SF, Wu YJ, et al. The clinical features and prognosis of lupus with disease onset at age 65 and older[J]. Lupus,2000,9(2) :96-100.
4[4]Ballou SP,Khan MA,Kushner Ⅰ. Clinical features of SLE: differences related to race and age of onset [ J ]. Arthritis Rheum,1982,25: 55-60.
5[5]Catoggio LJ, Skinner RP, Smith G, et al. SLE in the elderly: clinical and serological characteristics. 1984, 11: 175-181.
6[6]Cervera R, Khamashta MA, Font J, et al. SLE: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients[ J]. Medicine, 1993,72:113-124.
7[7]Font J, Pallares L, Cervera R, et al. SLE in the elderly: clinical and immunological characteristics [ J]. Ann Rheum Dis, 1991,50: 702-705.
8[8]Ho CTK, Mook CC, Lau CS, et al. Late onset SLE in southern Chinese[ J]. Ann Rheum Dis, 1998,57: 437-440.
9[9]Koh ET, Boey ML. Late onset lupus: a clinical and immunology study in a predominantly Chinese population[ J]. J Rheumatol,1994,21:1463-1467.
